Marion Procter
Impact in
- Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 29
- HER2/EGFR in Cancer Research 27
- Cancer Treatment and Pharmacology 7
- Peptidase Inhibition and Analysis 5
-
- Breast Cancer Treatment Studies 15
- Co-authors
- Martine Piccart (24 shared papers)Richard D. Gelber (19 shared papers)Evandro de Azambuja (22 shared papers)Thomas Suter (2 shared papers)Mitch Dowsett (11 shared papers)Giuseppe Viale (8 shared papers)Brian Leyland‐Jones (8 shared papers)José Baselga (5 shared papers)
- Journals
- Journal of Clinical Oncology (13 papers)Cancer Research (5 papers)Annals of Oncology (4 papers)Breast Cancer Research and Treatment (2 papers)The Breast (2 papers)
- Partner nations
- BelgiumSwitzerlandUnited Kingdom
In The Last Decade
Marion Procter
32 papers receiving 2.8k citations
Marion Procter's Hit Papers
Peers
Comparison fields: 5 of 81
- Oncology 1.7k
- Cancer Research 643
- Cardiology and Cardiovascular Medicine 608
- Radiology, Nuclear Medicine and Imaging 552
- Pulmonary and Respiratory Medicine 424
Countries citing papers authored by Marion Procter
This map shows the geographic impact of Marion Procter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion Procter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion Procter more than expected).
Fields of papers citing papers by Marion Procter
This network shows the impact of papers produced by Marion Procter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion Procter. The network helps show where Marion Procter may publish in the future.
Co-authors
The 25 scholars most cited alongside Marion Procter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer Hit paper breakdown → | 2017 | 940 |
| 2 | 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial Hit paper breakdown → | 2017 | 704 |
| 3 | 2007 | 403 | |
| 4 | 2014 | 182 | |
| 5 | 2010 | 179 | |
| 6 | 2009 | 148 | |
| 7 | 2019 | 42 | |
| 8 | 2012 | 32 | |
| 9 | 2022 | 31 | |
| 10 | 2013 | 31 | |
| 11 | 2013 | 23 | |
| 12 | 2012 | 20 | |
| 13 | 2009 | 17 | |
| 14 | 2017 | 9 | |
| 15 | 2016 | 8 | |
| 16 | 2015 | 7 | |
| 17 | 2021 | 5 | |
| 18 | 2019 | 5 | |
| 19 | 2018 | 5 | |
| 20 | 2007 | 5 |
About Marion Procter
Marion Procter is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Cardiology and Cardiovascular Medicine, having authored 34 papers that have together received 2.8k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (27 papers), Breast Cancer Treatment Studies (15 papers), Cancer Treatment and Pharmacology (7 papers), Advanced Breast Cancer Therapies (7 papers), Peptidase Inhibition and Analysis (5 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Radiomics and Machine Learning in Medical Imaging (1 paper) and Chemotherapy-induced cardiotoxicity and mitigation (1 paper). The work is most often cited by research in Oncology (1.7k citations), Cancer Research (643 citations), Cardiology and Cardiovascular Medicine (608 citations), Radiology, Nuclear Medicine and Imaging (552 citations) and Pulmonary and Respiratory Medicine (424 citations). Marion Procter has collaborated with scholars based in Belgium, Switzerland and United Kingdom. Frequent co-authors include Martine Piccart, Richard D. Gelber, Evandro de Azambuja, Thomas Suter, Mitch Dowsett, Giuseppe Viale, Brian Leyland‐Jones, José Baselga, David Cameron and Michael Untch. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, Breast Cancer Research and Treatment and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.